In Other News

• Research Sheds New Light on Genetic Risk Factors That Make Individuals More or Less Susceptible to Severe COVID-19

• Demand for COVID-19 Diagnosis to Help Point of Care CT Imaging Market Reach USD 276.9 Million by 2027

• Mast Group Launches New ESPLINE SARS-CoV-2 Lateral Flow Antigen Test

• Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test

• Russia’s Sputnik V COVID-19 Vaccine Shows 95% Effectiveness in Phase 3 Clinical Trials

• Cepheid Receives CE-IVD Registration for SARS-CoV-2, Flu A, Flu B and RSV Combination Test

• New AI Platform Detects COVID-19 on Chest X-Rays with Accuracy and Speed

• AstraZeneca-Oxford COVID-19 Vaccine Achieves Average 70% Efficacy Without Any Side Effects in Clinical Trials

• Antibody Cocktails at Low Doses Could Be More Effective at Treating COVID-19, Finds Study

• GE Healthcare Launches First X-Ray AI Algorithm to Help Assess Endotracheal Tube Placement for COVID-19 Patients

• AI Algorithm Combines CT Images with Non-Imaging Data to Accurately Predict COVID-19 Patient Outcomes

• Regeneron's REGEN-COV2 Becomes First Antibody Cocktail for COVID-19 to Receive FDA EUA

• Pfizer and BioNTech Submit Emergency Use Authorization Request to FDA for COVID-19 Vaccine

• Eli Lilly and Incyte’s Baricitinib Receives FDA EUA for Treatment of Hospitalized COVID-19 Patients

• Gilead's Remdesivir Should Not Be Used in Hospitalized COVID-19 Patients, Says WHO

• China’s Sinopharm Administers Unproven COVID-19 Vaccine to One Million People Without Any Serious Adverse Event

• Ortho's CE-Marked VITROS SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals

• Oxford COVID-19 Vaccine Triggers Robust Immune Response in Older Adults in Phase 2 Trial

• Moderna and Pfizer COVID-19 Vaccines Could Receive EUA in a Month and Rollout in Weeks

• Arthritis Drug Tocilizumab Found Effective in Treating Sickest COVID-19 Patients

• First Hybridization Capture-Based NGS Assay for Characterization and Surveillance of SARS-CoV-2 Launched

• Anti-COVID Nasal Spray `Ready for Use in Humans`

• FDA Authorizes First COVID-19 Test for Self-Testing at Home